Roadmapping The Journey To Going Public For Life Sciences Companies

By Jim Ingram, Business Development Representative, Sikich

Would going public be more manageable and low-risk if the right expertise and systems helped a company move through the process efficiently and established a firm foundation for its future? During our recent life sciences event, ‘Discovery to Delivery: Maneuvering the Milestones,’ Martin Beck, the CFO of UpHealth, and Jim Ingram, Business Development Executive at Sikich, discussed the challenges and complexities of life sciences organizations that aim to go public . When UpHealth went public, it followed a special purpose acquisition company (SPAC) approach, supported by expert guidance and powerful technology.